MedTrace Logo

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging

NCT06804759 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-02-03

No results posted yet for this study

Summary

A clinical study with approximately 40 subjects, aged 35-65 years of age, who must have crow's feet and at least one other type of facial fine lines/wrinkles in order to evaluate the efficacy of Activated Silk™ 27P-α to improve the signs of aging.

Conditions

  • Skin Aging

Interventions

OTHER

Investigational Facial Serum #1

Investigational Facial Serum #1 is made with Activated Silk™ 27P-α.

OTHER

Investigational Facial Serum #2

Investigational Facial Serum #2 is made with an active comparator.

OTHER

Investigational Facial Serum #3

Investigational Facial Serum #3 is a placebo comparator

Sponsors & Collaborators

  • Victoria Collotta

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-18
Primary Completion
2024-12-20
Completion
2025-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06804759 on ClinicalTrials.gov